BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11536244)

  • 1. No mutations of SAP/SH2D1A/DSHP and perforin genes in patients with Epstein-Barr virus-associated hemophagocytic syndrome in Japan.
    Ma X; Okamura A; Yosioka M; Ishiguro N; Kikuta H; Kobayashi K
    J Med Virol; 2001 Oct; 65(2):358-61. PubMed ID: 11536244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection in a patient with a novel mutation in the signaling lymphocytic activation molecule-associated protein.
    Halasa NB; Whitlock JA; McCurley TL; Smith JA; Zhu Q; Ochs H; Dermody TS; Crowe JE
    Clin Infect Dis; 2003 Nov; 37(10):e136-41. PubMed ID: 14583885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identical twin brothers concordant for Langerhans' cell histiocytosis and discordant for Epstein-Barr virus-associated haemophagocytic syndrome.
    Chen CJ; Ho TY; Lu JJ; Sheu LF; Lee SY; Tien CH; Cheng SN
    Eur J Pediatr; 2004 Sep; 163(9):536-9. PubMed ID: 15243808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
    Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
    Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
    Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
    Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Zhizhuo H; Junmei X; Yuelin S; Qiang Q; Chunyan L; Zhengde X; Kunling S
    Pediatr Blood Cancer; 2012 Mar; 58(3):410-4. PubMed ID: 21674762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene abnormalities in patients with hemophagocytic lymphohistiocytosis.
    Grunebaum E; Roifman CM
    Isr Med Assoc J; 2002 May; 4(5):366-9. PubMed ID: 12040827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene.
    Arico M; Imashuku S; Clementi R; Hibi S; Teramura T; Danesino C; Haber DA; Nichols KE
    Blood; 2001 Feb; 97(4):1131-3. PubMed ID: 11159547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of SLAM mutations in EBV-associated lymphoproliferative disease patients.
    Ferrand V; Li C; Romeo G; Yin L
    J Med Virol; 2003 May; 70(1):131-6. PubMed ID: 12629654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.
    Dupré L; Andolfi G; Tangye SG; Clementi R; Locatelli F; Aricò M; Aiuti A; Roncarolo MG
    Blood; 2005 Jun; 105(11):4383-9. PubMed ID: 15677558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.
    Chuang HC; Lay JD; Hsieh WC; Wang HC; Chang Y; Chuang SE; Su IJ
    Blood; 2005 Nov; 106(9):3090-6. PubMed ID: 16002423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses.
    Sumegi J; Seemayer TA; Huang D; Davis JR; Morra M; Gross TG; Yin L; Romco G; Klein E; Terhorst C; Lanyi A
    Leuk Lymphoma; 2002 Jun; 43(6):1189-201. PubMed ID: 12152986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencing.
    Ono S; Nakayama M; Kanegane H; Hoshino A; Shimodera S; Shibata H; Fujino H; Fujino T; Yunomae Y; Okano T; Yamashita M; Yasumi T; Izawa K; Takagi M; Imai K; Zhang K; Marsh R; Picard C; Latour S; Ohara O; Morio T
    Int J Hematol; 2018 Sep; 108(3):319-328. PubMed ID: 29777376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
    Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
    Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristic perforin gene mutations of haemophagocytic lymphohistiocytosis patients in Japan.
    Ueda I; Morimoto A; Inaba T; Yagi T; Hibi S; Sugimoto T; Sako M; Yanai F; Fukushima T; Nakayama M; Ishii E; Imashuku S
    Br J Haematol; 2003 May; 121(3):503-10. PubMed ID: 12716377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines.
    Nagy N; Cerboni C; Mattsson K; Maeda A; Gogolák P; Sümegi J; Lányi A; Székely L; Carbone E; Klein G; Klein E
    Int J Cancer; 2000 Nov; 88(3):439-47. PubMed ID: 11054674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.
    Erdõs M; Uzvölgyi E; Nemes Z; Török O; Rákóczi E; Went-Sümegi N; Sümegi J; Maródi L
    Hum Mutat; 2005 May; 25(5):506. PubMed ID: 15841490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.
    Booth C; Gilmour KC; Veys P; Gennery AR; Slatter MA; Chapel H; Heath PT; Steward CG; Smith O; O'Meara A; Kerrigan H; Mahlaoui N; Cavazzana-Calvo M; Fischer A; Moshous D; Blanche S; Pachlopnik Schmid J; Latour S; de Saint-Basile G; Albert M; Notheis G; Rieber N; Strahm B; Ritterbusch H; Lankester A; Hartwig NG; Meyts I; Plebani A; Soresina A; Finocchi A; Pignata C; Cirillo E; Bonanomi S; Peters C; Kalwak K; Pasic S; Sedlacek P; Jazbec J; Kanegane H; Nichols KE; Hanson IC; Kapoor N; Haddad E; Cowan M; Choo S; Smart J; Arkwright PD; Gaspar HB
    Blood; 2011 Jan; 117(1):53-62. PubMed ID: 20926771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members.
    Kogawa K; Lee SM; Villanueva J; Marmer D; Sumegi J; Filipovich AH
    Blood; 2002 Jan; 99(1):61-6. PubMed ID: 11756153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses.
    Sumazaki R; Kanegane H; Osaki M; Fukushima T; Tsuchida M; Matsukura H; Shinozaki K; Kimura H; Matsui A; Miyawaki T
    Blood; 2001 Aug; 98(4):1268-70. PubMed ID: 11493483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.